Cardiac ablation is one example of a device category that the Health Care Financing Administration should have included in a list of "new technology" eligible for additional reimbursement under Medicare's soon-to-be-implemented prospective payment system (PPS) for hospital outpatient procedures, the Health Industry Manufacturers Association says.
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Out-of-hospital cardiac arrest remains one of the most challenging and resource-intensive emergencies in cardiovascular care. At SCAI 2025, clinicians presented a novel algorithm that improved triage decisions and reduced unnecessary interventions.
A battle may be forming over the 2027 FDA user fee reauthorizations. At a conference Friday, Democratic Rep. Jake Auchincloss supports them for their effectiveness, while Deputy FDA Commissioner Grace Graham echoed criticisms from HHS Sec. Kennedy, among others, in calling for reform to ensure public trust.
Israeli-based SpotitEarly hopes to bring an early cancer-detection test, which uses dogs’ noses to detect compounds in exhaled breath and AI analysis, to US homes in 2026.
